SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit

BENSALEM, Pa., Oct. 24, 2024 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE). Class Period: April 12,…